Judy Garber, MD

Medical Oncology

Judy Garber, MD

View full profile

Related Videos

Judy Garber, MD, MPH Presents Updated Results of the OlympiA Study Video

Judy Garber, MD, MPH Presents Updated Results of the OlympiA Study

Dana-Farber’s Judy Garber, MD, MPH shared updated results from the phase 3 OlympiA study. The new analysis provides further support for olaparib’s benefits in patients with high-risk, HER2-negative breast cancer with germline mutations in BRCA1 or BRCA2.